Invus Financial Advisors’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-109,500
| Closed | -$1.6M | – | 9 |
|
|
2021
Q4 | $1.6M | Hold |
109,500
| – | – | 0.49% | 8 |
|
|
2021
Q3 | $3.29M | Hold |
109,500
| – | – | 0.88% | 8 |
|
|
2021
Q2 | $5.08M | Hold |
109,500
| – | – | 1.01% | 8 |
|
|
2021
Q1 | $6.57M | Hold |
109,500
| – | – | 1.51% | 7 |
|
|
2020
Q4 | $5.74M | Hold |
109,500
| – | – | 2.4% | 6 |
|
|
2020
Q3 | $3.79M | Sell |
109,500
-109,500
| -50% | -$3.79M | 1.82% | 6 |
|
|
2020
Q2 | $19M | Hold |
219,000
| – | – | 6.87% | 6 |
|
|
2020
Q1 | $12.7M | Hold |
219,000
| – | – | 6.24% | 5 |
|
|
2019
Q4 | $15.8M | Buy |
+219,000
| New | +$15.8M | 8.01% | 5 |
|